Ser269

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser269 - JIP4 iso2 (human)

Site Information
tPAsTANsDVAtIPT SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 5504044

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	breast cancer ( 1 ) , breast cancer, triple negative ( 1 )
Relevant cell line - cell type - tissue:	HCC1937 (breast cell) ( 1 )

References
1	Rikova K (2005) CST Curation Set: 1035; Year: 2005; Biosample/Treatment: cell line, HCC1937/serum starved; Disease: breast cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XX[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) Akt Substrate Antibody Cat#: 9611 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.